Shaham et al[67] reported aberrant expression of miR-486-5p regulated by the GATA1 gene in DS patients with myeloid leukemia, implicated in fostering survival of abnormal red blood cell phenotypes. The gene discussed is GATA1; the disease is Dravet syndrome.